脓毒症相关脑病的当前认识与挑战
本文为综述,总结脓毒症相关脑病(SAE)的流行病学、机制、特征与并发症。SAE是脓毒症常见并发症,ICU收治患者中发生率高达70%,表现为从谵妄到昏迷的意识状态恶化,也可出现脑电图改变和癫痫发作。SAE与死亡率升高相关,死亡率随临床表现和脑电图异常严重程度成比例上升,并常遗留长期认知障碍和功能残疾。其病理生理复杂,涉及神经递质传递紊乱及血脑屏障、神经血管耦联、突触等功能复合体障碍,神经炎症和缺血是主要过程,细胞机制包括生物能量衰竭和氧化应激,额叶皮质、海马、边缘系统和脑干尤为易损。当前管理主要依靠控制脓毒症和实施谵妄推荐(包括避免神经毒性药物),开发特异性治疗有赖于更深入理解病理生理及识别具有诊断、病理生理和/或预后价值的生物标志物。
要点
- SAE是脓毒症常见并发症,ICU收治患者中发生率高达70%,表现为从谵妄到昏迷的意识恶化,也可有脑电图改变和癫痫发作。
- SAE与死亡率升高相关,死亡率随临床表现和脑电图异常严重程度成比例上升,且常遗留长期认知障碍和功能残疾。
- 当前SAE管理主要依靠控制脓毒症和实施谵妄推荐,包括避免神经毒性药物,尚无特异性治疗。
- 神经炎症和缺血是SAE主要病理生理过程,细胞机制包括生物能量衰竭和氧化应激,额叶皮质、海马、边缘系统和脑干尤为易损。
- 开发SAE特异性治疗有赖于通过相关实验模型更好地理解病理生理,以及识别具有诊断、病理生理和/或预后价值的生物标志物。
适用人群与场景
- 脓毒症患者,尤其是收治ICU者,为SAE适用人群。
处置流程与药物剂量
- 当前管理主要依靠控制脓毒症和应用谵妄推荐,包括避免神经毒性药物。
- 开发SAE特异性治疗有赖于通过相关实验模型更好地理解病理生理,以及识别具有诊断、病理生理和/或预后价值的生物标志物。
研究设计与关键结果
- 综述总结:SAE在ICU收治的脓毒症患者中发生率高达70%,与死亡率升高相关,死亡率随临床表现和脑电图异常严重程度成比例上升,并常遗留长期认知障碍和功能残疾。
证据类型、等级与局限
- 证据类型:当代综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对脓毒症患者应认识SAE可从谵妄进展至昏迷并伴脑电图改变和癫痫发作,其死亡率随临床和脑电图异常严重程度成比例上升。
- 当前床旁管理按原文为控制脓毒症并实施谵妄推荐,包括避免神经毒性药物,尚无SAE特异性治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Encephalopathy is a common complication of sepsis, occurring in up to 70% of patients admitted to the intensive care unit. It is primarily characterized by a deterioration in condition, ranging from delirium to coma, but also by electroencephalographic changes and seizures. Sepsis-associated encephalopathy (SAE) is linked to increased mortality, which rises in proportion to the severity of both clinical manifestations and electroencephalographic abnormalities, and is frequently followed by long-term cognitive impairment and functional disability. The pathophysiology of SAE is complex and includes a disturbance in neurotransmission together with a dysfunction of different brain cells and functional complexes (blood-brain barrier, neurovascular coupling, synapses). Neuroinflammation and ischemia are its main processes. Its cellular mechanisms include bioenergetic failure and oxidative stress. The frontal cortex, hippocampus, limbic system, and brainstem are particularly vulnerable to these events. Currently, management relies primarily on controlling sepsis and applying recommendations for delirium, including the avoidance of neurotoxic agents. Developing a specific treatment would depend on a better understanding of its pathophysiology, through a relevant experimental model, as well as on the identification of biomarkers with diagnostic, pathophysiological, and/or prognostic value. This contemporary review synthesizes current data on the epidemiology, mechanisms, characteristics and complications of SAE, as well as priorities for therapeutic progress.
参考来源
- Shankar-Hari M, Benghanem S, Bourhy L, et al. Current knowledge and challenges of sepsis-associated encephalopathy. Intensive Care Med. 2026. PMID: 42301312. doi:10.1007/s00134-026-08489-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。